# Yijian Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/yijian-health

- Industry: Biotechnology
- Headquarters: Shanghai, China
- Website: www.yjmedlab.com
- Latest round: Series A (Dec 5, 2025)
- Investors on record: 1

## About

Established in 2019 and based in Shanghai, China, Yijian Health is a healthcare company that provides genetic testing services and LIMS software. The company's subsidiary is called Shanghai Yiken Medical Testing Laboratory Co. Ltd. The company has a medical laboratory of nearly 2000 square meters. More than 90% of the company's staff have a background in molecular biology and clinical laboratory medicine. The company cooperates with Fudan University Cancer Hospital, Shengjing Hospital of China Medical University, and other institutions. The company engages in gene testing services. The testing projects includes tumor early screening, tumor targeting, chemotherapy, immunotherapy drug evaluation, chronic disease safety drug evaluation and etc. The company also provides a healthcare information platform called LIMS system. The system provides medical research and development process management such as sample acceptance, sample testing, statistical analysis. Following the funding in 2022, the company plans to focus on new products research and development, market promotion. In December 2025, Yijian Health closed Series A+ funding from new investor Caitong Capital.

## Funding rounds

- Series A, Dec 5, 2025 — Caitong Capital

## Investors

- Caitong Capital (https://capitalatlas.ai/funds/caitong-capital) — Series A